- Home
- GNLN vs SNOA Comparison
GNLN vs SNOA Comparison
Compare GNLN & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLN
- SNOA
- Stock Information
- Founded
- GNLN 2005
- SNOA 1999
- Country
- GNLN United States
- SNOA United States
- Employees
- GNLN N/A
- SNOA N/A
- Industry
- GNLN Durable Goods
- SNOA Biotechnology: Pharmaceutical Preparations
- Sector
- GNLN Consumer Discretionary
- SNOA Health Care
- Exchange
- GNLN Nasdaq
- SNOA Nasdaq
- Market Cap
- GNLN 1.6M
- SNOA 3.6M
- IPO Year
- GNLN 2019
- SNOA 2007
- Fundamental
- Price
- GNLN $0.51
- SNOA $3.08
- Analyst Decision
- GNLN
- SNOA
- Analyst Count
- GNLN 0
- SNOA 0
- Target Price
- GNLN N/A
- SNOA N/A
- AVG Volume (30 Days)
- GNLN 325.8K
- SNOA 4.5M
- Earning Date
- GNLN 11-15-2024
- SNOA 02-05-2025
- Dividend Yield
- GNLN N/A
- SNOA N/A
- EPS Growth
- GNLN N/A
- SNOA N/A
- EPS
- GNLN N/A
- SNOA N/A
- Revenue
- GNLN $21,605,000.00
- SNOA $13,973,000.00
- Revenue This Year
- GNLN $72.27
- SNOA $23.89
- Revenue Next Year
- GNLN $93.46
- SNOA $25.45
- P/E Ratio
- GNLN N/A
- SNOA N/A
- Revenue Growth
- GNLN N/A
- SNOA 13.51
- 52 Week Low
- GNLN $0.48
- SNOA $1.90
- 52 Week High
- GNLN $21.80
- SNOA $9.40
- Technical
- Relative Strength Index (RSI)
- GNLN 18.13
- SNOA 61.41
- Support Level
- GNLN $0.51
- SNOA $1.90
- Resistance Level
- GNLN $0.58
- SNOA $4.46
- Average True Range (ATR)
- GNLN 0.06
- SNOA 0.39
- MACD
- GNLN 0.01
- SNOA 0.13
- Stochastic Oscillator
- GNLN 9.35
- SNOA 46.09
About GNLN Greenlane Holdings Inc.
Greenlane Holdings Inc is a distributor of vaporization products and consumption accessories in the United States. It offers a selection of stock-keeping units including vaporizers and parts, cleaning products, grinders and storage containers, pipes, rolling papers and customized lines of premium specialty packaging. The company markets and sells its products in both the business to business and business to consumer sectors of the marketplace. Its geographical segment includes the United States; Canada and Europe. It derives a majority of revenue from the United States.
About SNOA Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.